A clinical-stage biotechnology company headquartered in Philadelphia, Pennsylvania, with research and development operations ...

TECregen, a Swiss biotech advancing thymus regeneration, has announced the successful completion of a 10 million Swiss francs ...

The launch of USA-based Poplar Therapeutics has been announced, alongside a $50 million Series A financing led by SR One, ...

UK biotech Engitix has raised a $25 million series A extension from existing investor Netherton Investments, investing on behalf of BlueCrest Capital Management co-founder Mike Platt. The funding will ...

Swiss specialty drugmaker Santhera Pharmaceuticals announces it has signed an exclusive licensing agreement with Nxera Pharma ...

European private equity company Andera Partners today announced that it is co-leading a $159.8 million Series A round of ...

Swiss biotech TECregen has raised 10 million Swiss francs ($12.6 million) in seed financing to advance its thymus ...

Independent French pharma major Servier today announced the creation of Servier Ventures, a fully owned corporate venture ...

UK-based clinical-stage ophthalmic gene therapy biotech Beacon Therapeutics today announced that it has raised over $75 ...

Danish biotech Genmab (Nasdaq: GMAB) has partnered with artificial intelligence company Anthropic to deploy agentic AI tools ...

Indian drugmaker Granules India (BSE: 532482) has announced its US subsidiary has secured tentative approval from the ...

AstraZeneca’s new head of Investor Relations, Joris Silon, succeeds Andy Barnett on 1 March 2026, and will be based in ...